[Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
作者信息
Heidenreich A
机构信息
Klinik und Poliklinik für Urologie, Universität zu Köln.
出版信息
Urologe A. 1997 Nov;36(6):568.
PMID:9487597
Abstract
摘要
相似文献
1
2
The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.双膦酸盐用于激素难治性前列腺癌所致疼痛性骨转移的姑息治疗。
J Urol. 2001 Jan;165(1):136-40. doi: 10.1097/00005392-200101000-00033.
3
The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.氯膦酸盐与安慰剂相比对前列腺癌骨转移疼痛患者的镇痛疗效。
Anticancer Res. 1997 Nov-Dec;17(6D):4717-21.
4
Prostate cancer and bone metastases. The effect of clodronate.
Ann Chir Gynaecol. 1998;87(1):59-60.
5
Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
Prostate Cancer Prostatic Dis. 2004;7(4):350-4. doi: 10.1038/sj.pcan.4500752.
6
Clodronate in the management of bone metastases: a clinical study of 91 patients.
Neoplasma. 1999;46(5):317-22.
7
[Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma].
Urologe A. 1992 Mar;31(2):63-6.
8
9
Zotero 插件